|
* Breaking Mexican laws regarding purchasing of drugs may lead to your arrest in the Mexico.
7/7 Lilly Gets Nod For Expanded Use Of Alimta
Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
maintenance therapy for locally advanced or metastatic non-small cell lung cancer (NSCLC) . |
Customs and Border Protection
U.S. |
| market
[Reuters]
7/6 NEJM Article Challenges Conventional Diabetic Wisdom:
ACE Inhibitors, ARBS Fail To Ameliorate Nephropathy In Type 1's
ACE, ARB Slow Retinopathy but Not Nephropathy in Type 1 Diabetes
unexpected and unexplained" increase in microalbuminuria
285 patients with type 1 diabetes but normal albumin excretion and blood pressure levels. Placebo
Likely FDA Approval Gives Dendreon A Lift
extended survival by a median 4. |
People were classed in one of four groups: those who had no drug coverage before Medicare Part D; those who had drug coverage but with a cap of $150 a quarter (considered limited coverage); those who had a cap of $350 a quarter; and those who received uncapped drug coverage from their former employer for the entire four years of the study, considered the control group. |
| Unknowingly breaking the law, or getting a Mexican prescription, even unknowingly, from someone who is not authorized to issue it does not excuse a U.
* If you lie to customs about having drugs and you are caught, the consequences could be simple, like having the drugs taken away, or very serious, such as going to jail. |
WEDNESDAY, July 1 (HealthDay News) -- Older people who signed up for Medicare's prescription drug coverage, called Part D, spent more on drugs after enrolling than they had before but less on other types of medical care, researchers have found. |
| Food and Drug Administration last month seized more than 30 of its generic drugs for QC violations such as oversized pills.gov]
7/6 Zevalin: Complete Response Letter
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for Zevalin
Does Not Involve New Clinical Studies or New Data Analyses
FDA requested the Company to submit data files from the FIT study to support and verify a subset of the data that are currently under review
[Spectrum Pharmaceuticals Press Release]
7/6 Provenge Approval Possible Mid-1010 Launch;
Efficacy = Extra 4 Months Vs. |
One surprise was that drug spending actually went up in the group that had the most coverage before joining Part D. |
| This seemed to correlate with an improvement in greater ability to afford medications, the study found. "We always said there would be savings in other parts of the system. |
That research, from the University of Maryland School of Pharmacy and funded by Novartis Pharmaceuticals, found "small but statistically significant" improvements in health status, based on daily activity levels, of those enrollees who previously had no prescription drug coverage.
Architects of the plan hoped that better adherence to medication regimens would, in turn, result in better health outcomes and lower overall health costs. |
96 by the log-rank test)
[NEJM]
7/6 Sepracor: 2 Lunesta For Kids Experiments Put On Hold
Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA(R) Pediatrics
FDA has notified us that these two studies have been put on clinical hold due to its concerns regarding non-clinical data that could be relevant to the administration of eszopiclone in children
[Sepracor Press Release]
See Also: Safety & Efficacy Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder - Associated Insomnia
[ClinicalTrials.
canine tramadol doseage |
People who'd had no drug coverage increased their spending on drugs, on average, by 74 percent ($41 a month), those with a cap of $150 increased spending by 27 percent ($27 a month) and those with a $350 quarterly cap increased spending by 11 percent ($13), compared with the control group., but would be used to blunt the effect of an expected shortage in Gaucher's disease drug made by Genzyme Corp
[BizJournal]
See Also: Protalix Asked to Widen Gaucher-Drug Supply
[Wall Street Journal; $$$]
See Also: Protalix's New Carrot Derived Drug Likely to Win FDA Approval
[CNBC]
7/7 Generic Maker Caraco Lays Off 1/2 Workforce; Quality Control Lapse
Caraco Pharmaceuticals lays off 350
jobs indefinitely after federal authorities shut down distribution at all the company's Michigan plants last month citing faulty manufacturing practices
[Detroit News]
See Also: Similar Report From NASDAQ; adds U. |
16 ; as a frame of reference, generic maker Taro has a market cap of $311mln (similar P/E) and Mylan is worth $3. GLP-1 Shot
Misses 1st Line Nod, Use W/Insulin; Launch Before 2009 Ends
Novo Nordisk A/S -- Regulatory Approval
combination treatment with metformin or a sulphonylurea in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin or sulphonylurea,
combination treatment with metformin and a sulphonylurea or metformin and a thiazolidinedione in patients with insufficient glycaemic control despite dual therapy
[Novo Press Release]
Novo Nordisk says Victoza cleared for EU market
thyroid tumours found in tests of rats and mice .
generic tramadol tramadol and price |
S. Customs permits people to bring back reasonable amounts of medications for personal use, but does not allow stockpiling or purchasing large amounts of drugs for what will be assumed is a commercial or resale purpose. |
|
7/7 Aricept Patent Battle Gordian Knot Head Scratcher
Apotex Challenges Eisai's Patents on Alzheimer's Drug Aricept
A bottle with 180, 10- milligram tablets of Aricept costs $1,155. |
7/7 Genzyme's Pain Is Upstart Israeli's Gain
FDA considers new Gaucher drug to offset Genzyme's plant shutdown
not yet been approved for use in the U. |
|
Editor's Note: Caraco is the smaller generic makers in the USA; it's trading for a little more than $3/Share; and has a market cap of $115 million and a P/Eof 6. |
Serious Risks When You Buy Prescription Drugs in Mexico
* Drugs you purchase in Mexico may be counterfeit. Department of State, Consular Information on Mexico
Disclaimer: Laws are constantly changing, and the guidelines mentioned here are subject to change without notice. |
| 3). delaying -- and possibly blocking -- the drug's launch in the all-important U. |
Get Current Information About Regulations on Importing Drugs From Mexico
U. |